Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2019

01-09-2019 | Original Article

Reporting quality of 2014–2018 clinical practice guidelines on diabetes according to the RIGHT checklist

Authors: Qianmei Wang, Yuting Duan, Jielin Liang, Ze Chen, Juexuan Chen, Yan Zheng, Yaolong Chen, Chunzhi Tang

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Objective

Reporting Items for Clinical Practice Guidelines (CPGs) in HealThcare (RIGHT) checklist was used as a tool to assess the reporting quality of 2014–2018 CPGs on diabetes treatment, aiming to promote the application of RIGHT and improve the reporting quality of future guidelines.

Methods

We searched Chinese Biomedical Literature Service System (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP database, Medline, Embase, Allied, and Complementary MEdicine Database (AMED), and Medlive and Google Scholar (Google academics), and collected published CPGs on diabetes with published date during 1st January, 2014 and 7th November, 2018. CPGs on diabetes issued since 2014 were included and filtered by two reviewers independently. Then the basic information extraction and RIGHT evaluation of the included CPG are carried out.

Results

A total of 34 guidelines were included, out of which 7 are for Chinese and 27 for other countries. Overall, basic information (domain 1) got the highest (64.66%) reporting rate, while financing and conflict-of-interest statements and management (domain 6) got the lowest (8.1%). For all guidelines, classification of guidelines (item 1c) was sufficiently reported, and description of the specific sources of funding for all stages of guideline development (item 18a) was not reported. For Chinese CPGs, financing and conflict-of-interest statements and management (domain 6) was most insufficiently reported, and only identification of guideline in the title (item 1a), corresponding information of the developer or author (item 4), description of basic epidemiology (item 5), and subgroup description (item 7b) out of 22 items were better reported than foreign guidelines.

Conclusions

Overall, the CPGs on diabetes during 2014–2018 adhered to ~41% RIGHT checklist, of which Chinese CPGs adhered less than that of foreign guidelines. It is suggested that the RIGHT reporting checklist should be endorsed and used by CPG developers to ensure higher quality and adequate use of guidelines.
Appendix
Available only for authorised users
Footnotes
1
In Figs. 2 and 3: Domain 1: Basic information, Domain 2: Background, Domain 3: Evidence, Domain 4: Recommendations, Domain 5: Review and quality assurance, Domain 6: Funding and declaration and management of interests, Domain 7: Other information.
 
Literature
1.
M.J. Field, K.N. Lohr, Clinical Practice Guidelines: Directions for a New Program (National Academies Press, Washington DC, 1990)
2.
Y. Li. Evidence-based Medicine (People’s Medical Publishing House, Beijing, 2014)
3.
R. Chen, Y. Chen, G. Gai, Y. Xie, Y. Wang, Reporting specification for practice guidelines for sepsis analysis based on right standards. Chin. J. Tradit. Chin. Med. 42(8), 1514–1517 (2017)
4.
C. Y, Y. K, M. A, A reporting tool for practice guidelines in health care: the RIGHT statement. Ann. Intern. Med. 2(166), 128–132 (2017)
5.
R. Tokalić, M. Viđak, I. Buljan, A. Marušić, Reporting quality of European and Croatian health practice guidelines according to the RIGHT reporting checklist. Implement. Sci. 13(1), 135 (2018)CrossRefPubMedPubMedCentral
6.
L. Ke, Y. Mu, Y. Chen. Evaluation of the quality of the clinical practice guide published in Chinese mainland journals in 2016. Chin. J. Evid. Based Pediatr. 13(03), 194–199 (2018)
7.
Guidelines for the treatment of insulin pumps in China (version 2014). (2014)
8.
Guidelines for grading diagnosis and treatment of Diabetes in Anhui Province, 2 (Anhui medicine, 2016)
9.
L. Guo, Insulin therapy guidelines for type 1 diabetes in China. Chin. J. Diabetes Mellitus 10(8), 591–597 (2016)
10.
W. Jia. Guidelines for the Prevention and treatment of Type 2 Diabetes in China (2017 Edn.). Chin. J. Diabetes 10(1), 4–67 (2017)
11.
Z. Fang, X. Tong, J. Duan, Evidence-based clinical practice guide of traditional Chinese medicine in pre-diabetes mellitus. J. Tradit. Chin. Med. 58(3), 266–270 (2017)
12.
Recommendations for dietary guidelines for diabetes mellitus. Med. Ther. Health Care 0(10), (2017)
13.
H. Yuan, Z. Yang, X. Shi, Guidelines for prediabetic intervention in the elderly. Chin. Geriatr. Health Care 16(3), 23–24 (2018)
14.
Guidelines on the Management and Prevention of Prediabetes. Acta Medica Indonesiana - The Indonesian Journal Internal Medicine 4(46), 348–359 (2014)
15.
S. Shah, S. Sharma, P. Singh, A. Muruganathan, A.K. Das. Consensus Evidence-based Guidelines for Insulin Initiation, Optimization and Continuation in Type 2 Diabetes Mellitus. Supplement to J. Assoc. Physicians India 62, 49–54 (2014)
16.
B. Redmon, D. Caccamo, P. Flavin, R. Michels, P. O’Connor, J. Roberts, S. Smith, J. Sperl-Hillen. Diagnosis and Management of Type 2 Diabetes Mellitus in Adults. Institute for Clinical Systems Improvement (2014)
17.
Ministry of Health, Singapore. Diabetes Mellitus - MOH Clinical Practice Guidelines (2014)
18.
M. Mata-Cases, S. Artola, J. Escalada, P. Ezkurra-Loyola, J.C. Ferrer-García, J.A. Fornos, et al. Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society. Rev. Clin. Esp. 215, 117–129 (2015)
19.
Korean Diabetes Association. Treatment Guidelines for Diabetes, 5th edn. (2015)
20.
Clinical Practice Guidelines Management of Type 2 Diabetes Mellitus, 5th edn. (2015)
21.
AACE/ACE, Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan. AACE/ACE Diabetes Guidelines, Endocr. Pract. 21(Suppl 1), (2015)
22.
The Japan Diabetes Society: Japanese Clinical Practice Guideline for diabetes 2016. Tokyo: Nankodo. (2016)
23.
M.P. Aschner, O.M. Muñoz, D. Girón, O.M. García, D.G. Fernández-Ávila, L.Á. Casas, L.F. Bohórquez, T.C.M. Arango, L. Carvajal, D.A. Ramírez, J.G. Sarmiento, C.A. Colon, G.N.F. Correa, R.P. Alarcón, S.Á.Á. Bustamante. Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. Colomb Med. (Cali). 47(2), 109–31 (2016)
24.
The Royal Australian College of General Practitioners. General practice management of type 2 diabetes: 2016–18. East Melbourne, Vic: RACGP (2016)
25.
National Institute for Health and Care Excellence: Type 1 diabetes in adults: diagnosis and management. London: NICE (NG17) (2016)
26.
A. Qaseem, M.J. Barry, L.L. Humphrey, M.A. Forciea. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann. Intern. Med. 166(4):279–290 (2017)
27.
International Diabetes Federation. Recommendations For Manag ing Type 2 Diabetes In Primary Care (2017)
28.
Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of glycaemic control in people with type 2 diabetes. Edinburgh: SIGN. (2017)
29.
P.R. Conlin, J. Colburn, D. Aron, R.M. Pries, M.P. Tschanz, L. Pogach. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus. Ann. Intern. Med. 167(9), 655–663 (2017)
30.
M.J. Franz, J. MacLeod, A. Evert, C. Brown, E. Gradwell, D. Handu, A. Reppert, M. Robinson. Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Systematic Review of Evidence for Medical Nutrition Therapy Effectiveness and Recommendations for Integration into the Nutrition Care Process. J. Acad. Nutr. Diet. 117(10),1659–1679 (2017)
31.
S. Bajaj. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. Int. J. Diabetes Dev. Ctries. 38(Suppl 1), 1–115 (2018)
32.
National Institute of Health and Care Excellence. Type 2 diabetes in adults: management. London: NICE 2015. (NG28). (2017)
33.
AACE/ACE, Consensus statement: consensus statement by the american association of, clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm. Endocr. Pract. 24(1), 91–120 (2018)
34.
Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. Geneva: World Health Organization. Licence: CC BY-NC SA 3.0 IGO (2018)
35.
S. Kalra, S. Bahendeka, R. Sahay, S. Ghosh, F. Md, A. Orabi, et al. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International task force. Indian J. Endocr. Metab. 22, 132–157 (2018)
36.
2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clinical Diabetology. 7(1), 1–90 (2018)
37.
A. Qaseem, T.J. Wilt, D. Kansagara, C. Horwitch, M.J. Barry, M.A. Forciea. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus. Ann. Intern. Med. 168(8), 569–576 (2018)
38.
Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diabetes. 42(Suppl 1), S1–S325 (2018)
39.
American Diabetes Association. 1. Improving care and promoting health in populations: Standards of Medical Care in Diabetes-2018. Diabetes Care 41(Suppl 1), S7–S12 (2018)
40.
P.A. Dyson, D. Twenefour, C. Breen, A. Duncan, E. Elvin, L. Goff et al. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med. 35(5), 541–547 (2018)
41.
C.A. Chong, I. Chen, G. Naglie, M.D. Krahn, How well do guidelines incorporate evidence on patient preferences? J. Gen. Intern. Med. 24(8), 977–982 (2009)
Metadata
Title
Reporting quality of 2014–2018 clinical practice guidelines on diabetes according to the RIGHT checklist
Authors
Qianmei Wang
Yuting Duan
Jielin Liang
Ze Chen
Juexuan Chen
Yan Zheng
Yaolong Chen
Chunzhi Tang
Publication date
01-09-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02005-9

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue

Correction

Correction to: Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus

Original Article

Ethnic differences in body composition, sociodemographic characteristics and lifestyle in people with type 2 diabetes mellitus living in Italy

Meta Analysis

Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus

Original Article

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

Original Article

Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto’s thyroiditis. A nationwide Danish register study

Original Article

H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits